Learn how The Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai is advancing women’s health care through innovative research, excellence in patient care, and our commitment to global and public health initiatives. Under the leadership of Joanne Stone, MD, MS, our nationally renowned experts are transforming the delivery of women’s health care at every stage of life and preparing our next generation of leaders.
The Department of Obstetrics and Gynecology at The Mount Sinai Hospital is nationally ranked by U.S. News & World Report® for 2024-25.
Learn how The Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai is advancing women’s health care through innovative research, excellence in patient care, and our commitment to global and public health initiatives. Under the leadership of Joanne Stone, MD, MS, our nationally renowned experts are transforming the delivery of women’s health care at every stage of life and preparing our next generation of leaders.
Four important areas across the lifespan—endometriosis, cervical cancer, preeclampsia, and menopause—are the focus of a $3 million gift from the Pershing Square Foundation to support women’s health research.
At the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science, we are dedicated to our patients’ care across the lifespan, and to training the next generation of reproductive health leaders.
The Mount Sinai-Rainbow Clinic is the first of its kind in the United States. Its multidisciplinary team members have special training to understand and respond to the special circumstances and sensitivities of parents who have experienced perinatal loss.
Mount Sinai is expanding its post-discharge phone calls to include obstetric patients following a vaginal birth—who account for 60 percent of the Health System’s more than 11,000 yearly deliveries.
Earlier reviews summarized the research on outpatient cervical ripening, but did not reach a consensus about which methods are safest and most effective.
Physician-scientists at the Icahn School of Medicine at Mount Sinai launched a series of clinical trials to test promising treatments for gynecologic cancers, including antibody-drug conjugates, a new and highly targeted approach.
People who develop diabetes following pregnancy were significantly less likely to be able to bring it under control if they had experienced gestational diabetes mellitus during their pregnancy, especially if they were Black or Hispanic.
The Icahn School of Medicine at Mount Sinai has received a $4.6 million gift from The Pershing Square Foundation to support women’s health research and advance careers for female scientists.
The Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science is offering a one-day hybrid event designed to provide information and tools on perinatal loss.
Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset of ovarian cancer ...
Women with liver disease who underwent standard in vitro fertilization treatment showed no statistically significant differences in the rates of conception, pregnancy loss, or live births compared to women without liver disease...
This study is the first to examine in utero exposure to stimulants and long term child outcomes. Researchers examined almost 900 children who were exposed to ADHD during the mothers’ pregnancy and 1270 children who were not.
In 2022, Mount Sinai launched the Bridge Program, an initiative that provides integrated prenatal care and substance use treatment, an overlooked area that is vital to the health of many pregnant people.
A renowned expert in maternal fetal medicine is joining Mount Sinai to establish the Institute of Female Biology and pursue understudied areas in women’s health research.
People who are at higher risk of developing ovarian cancer due to an inherited genetic mutation—often referred to as previvors—are increasingly considering risk-reducing in which fallopian tubes but not ovaries are removed.
A multidisciplinary team included specialists in maternal fetal medicine, high-risk obstetrics, gynecologic oncology, and fibroid surgery and treatment.
In the aftermath of the Supreme Court ruling overturning Roe v. Wade, abortion has been banned in 15 states, and high-risk pregnant patients face a far more restrictive landscape.
At the Department of Obstetrics, Gynecology and Reproductive Science, we are dedicated to our patients’ care across the lifespan, and to training the next generation of expert reproductive health leaders.
Structural racism was associated with increased risk of COVID-19 infection and preterm births, in a study that is part of the Generation C project, following Mount Sinai participants through pregnancy and birth amid the pandemic.
A range of options, including egg donation, co-IVF, and intrauterine insemination, are informed by research and a commitment to health equity and inclusion.
While people who are pregnant can easily learn how to safeguard their physical health and that of their babies, information about mental health concerns is scarcer.
Immigrant pregnant people faced persistent inequities in obtaining timely prenatal care as compared with native-born pregnant people in the United States over an eight-year period.
New data from the longitudinal Stress in Pregnancy Study have identified earlier onset and higher rates of developmental psychopathology among children whose mothers were pregnant during Superstorm Sandy.
People who delivered during the COVID-19 pandemic were more likely to experience hypersensitive disorders of pregnancy, medically indicated preterm birth, and PPH even in the absence of SARS-CoV2 infection.
As we all carried on another busy year in medicine—facing the demands of patient care amid continuing waves of COVID-19—Mount Sinai’s Department of Obstetrics, Gynecology and Reproductive Science has been changing and growing.
As we all carried on another busy year in medicine—facing the demands of patient care amid continuing waves of COVID-19—Mount Sinai’s Department of Obstetrics, Gynecology and Reproductive Science has been changing and growing.
